Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q3 EPS of ($0.31), in-line with the analyst estimate of ($0.31). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.55 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2023 revenue of ~$22 million, versus the consensus of $22.26 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.